Indian
Shareholders to take call on listing: Future Generali India MD
India continues to be most attractive market for insurance players...
Aditya Birla Group to invest Rs 1,250 crore into its financial services arm
The board of Aditya Birla Capital Ltd (ABCL), which is into...
IRDAI issues norms for deploying `Bima Vahaks’ to enhance insurance inclusion
There can be Corporate Bima Vahak, who are legal person registered...
LIC,SBI among top 10 Indian brands in terms of value
Tata Consultancy Services (TCS) topped the 2023 50 Most Valuable...
International
UK’s Sunak wants insurers to explore products for social care costs
Social care refers to long-term health care outside hospitals.Sunak has asked officials to work with insurers to consider “new products” that can help with social care costs, the treasury source said.
“We’re hopeful that in time the cap on costs will provide the clarity insurers need to create new products,” the source said.
Cybersecurity seen as rising risk for airlines after 9/11
the embrace of digital technology has created new opportunities for trouble, with hackers able to penetrate systems through suppliers’ software, online services or WiFi offered to passengers.
Experts consider the potential for a hacker to take control of the plane itself as unlikely, since flight controls are separate from systems used by customers.
U.S. lawmakers seek $1 bln to fund FTC privacy probes
The proposal, which Democrats plan to include in a $3.5 trillion spending measure, would fund a new bureau over 10 years to address “unfair or deceptive acts or practices relating to privacy, data security, identity theft, data abuses, and related matters,” according to a summary released by the House Energy and Commerce Committee.
The committee will meet on Monday to take up the wide-ranging spending proposal that includes $30 billion to remove lead pipes and $13.5 billion for zero emissions vehicle infrastructure buildout.
Nerve disorder listed as ‘very rare’ side effect of AstraZeneca jab
Guillain-Barre Syndrome was a “very rare” side effect, occurring in under one in 10,000 people, it added. The disorder is a nerve inflammation that may cause temporary paralysis and difficulty breathing. In the United States, the very rare syndrome affects an estimated 3,000 to 6,000 people each year and most go on to recover.
The US Food and Drug Administration also warned in July of an “increased risk” of developing the neurological syndrome with Johnson & Johnson’s dose. Both regulators stressed that the vaccine’s benefits outweighed the potential
Briefs
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Advertisement
Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Features
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Data
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Interviews
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Facts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
